Hensoldt's €10.4 Billion Backlog: When Record Orders Aren't Enough to Please the Market
Published on 08/02/2026 at 22:31 | Redaktion boerse-global.de
The arithmetic of defense contracting has a peculiar quirk: a company can post its strongest booking figures ever and still watch its share price slide. That was the scene on Friday as Hensoldt released its first-half 2026 results, with the Munich-based sensor and radar specialist seeing its stock drop 4.64 percent to close at €79.76 — a reaction that left analysts scrambling to explain the disconnect between the numbers and the market's mood.
The Numbers Behind the Headlines
The operational picture, on its face, could hardly look stronger. Order intake for the first six months came in at €2.812 billion, double the €1.405 billion recorded in the same period last year. That surge pushed the order backlog past the psychologically significant €10 billion threshold for the first time, landing at €10.356 billion. Revenue climbed 23.6 percent to €1.167 billion, while adjusted EBITDA rose 28.5 percent to €137 million, with the margin improving from 11.3 percent to 11.8 percent. Adjusted free cash flow remained in negative territory at minus €136 million, though that marked an improvement from the minus €181 million posted a year earlier.
The momentum had been building all year. The first quarter alone saw order intake double to €1.48 billion, with the backlog already sitting at €9.8 billion at that stage. The second quarter accelerated the trend, and the company's role as the German partner in Project Freyja alongside Ukrainian defense firm Fire Point has added further demand to the pipeline.
Where the Growth Is Coming From
The Optronics segment delivered the standout performance, with order intake leaping from €164 million to €971 million. The jump was driven by major contracts for the Puma infantry fighting vehicle and the Schakal reconnaissance vehicle — a reminder of how forcefully land-systems demand is reshaping the European defense landscape.
The Market's Disappointment
So why the sell-off? The most plausible explanation lies in expectations that had built up ahead of the release. With the first half coming in so strong, many market participants had positioned for an upward revision to the full-year guidance. Management instead confirmed the existing targets: revenue of roughly €2.75 billion for 2026, an adjusted EBITDA margin between 18.5 and 19.0 percent, and a book-to-bill ratio in the range of 1.5x to 2.0x.
The absence of a guidance hike, despite record-breaking figures, was read by some as a signal that growth could be hitting its limits. Capacity constraints in European defense electronics production are emerging as a genuine concern — orders are arriving faster than manufacturing lines can be scaled up, and the lag between booking and delivery is precisely what appears to be weighing on investor sentiment. A growing backlog, after all, only translates into revenue and profit as quickly as the factory floor allows.
That same bottleneck between planning and execution plays out in workplace safety too — a documented risk assessment is only useful if it is actually current and complete before an incident occurs. A free toolkit with 41 ready-to-use templates and checklists helps you close that gap quickly, covering everything from fire safety to lone working. Download the free Risk Assessment Toolkit
A Familiar Pattern Across the Sector
Hensoldt is hardly alone in facing this dynamic. Rheinmetall posted a 69 percent revenue increase in the second quarter of 2026, yet found itself fielding investor questions about heavy capital expenditure and the potential loss of work tied to the cancelled F126 program. The broader European defense complex is wrestling with the same fundamental question: whether explosive order growth will convert into profitable revenue growth, or whether supply chain bottlenecks and capacity ceilings will blunt the translation.
Analysts Split Down the Middle
Friday's analyst commentary laid bare the valuation debate. Jefferies maintained its "Buy" rating with a €94.00 price target, praising the record order book and a slight beat against its own forecasts. Warburg Research also reaffirmed "Buy" with a €91.00 target, calling the second quarter convincing on the strength of profitable revenue growth.
On the other side stood mwb research, which kept its "Sell" recommendation and €62.00 price target, citing a rich valuation of 13.4x EV/EBITDA based on 2028 estimates and doubts about whether current order levels can be sustained beyond that year. JPMorgan held the middle ground with "Neutral" and an €85.00 target, noting that Hensoldt carries the highest valuation in its peer group — with analysts seeing more upside at competitors like the Renk Group.
The spread between the four price targets — from €62 to €94 — illustrates just how far apart the market's views on this stock have drifted.
Context for the Slide
Friday's decline needs some perspective. Over the past 30 days, the stock is still up 12.37 percent, suggesting the drop looks more like profit-taking after a strong run than a fundamental loss of confidence. That said, the gap to the 52-week high of €115.10 from October has widened to 30.70 percent, and the shares remain well below their peak even as they trade in positive territory for the year.
What's on the Horizon
The company has a busy calendar ahead. On July 24, Defense Minister Boris Pistorius joined Hensoldt's management to open a new corporate campus, with a focus on high-performance radars including the TRML-4D. The luWES tender for underwater weapons systems, expected in August, could serve as a further catalyst. Hensoldt is scheduled to present at the Commerzbank & ODDO Corporate Conference in Frankfurt on September 2, release third-quarter figures on November 5, and host a capital markets day in London on November 10.
When production capacity is stretched thin, the last thing any operation needs is downtime from a preventable safety failure. Over 37,000 UK businesses already rely on a free health and safety toolkit with ready-made risk assessments and checklists covering COSHH, PUWER and more — so you can stay compliant without pulling resources off the line. Get the free Health & Safety Toolkit
Between now and then, the central question for investors remains whether Hensoldt can convert its historic backlog into corresponding revenue growth — and how quickly European production capacity for defense electronics can be expanded to meet the demand that keeps pouring in.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
